Company Announcement COPENHAGEN, Denmark; April 22, 2024 “ Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5...
Company Announcement Net sales of DARZALEX® in the first quarter of 2024 totaled USD 2,692 millionGenmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen) COPENHAGEN,...
Company Announcement COPENHAGEN, Denmark; April 15, 2024 “ Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5...
Genmab bulks ADC pipeline with $1.8-billion purchase of ProfoundBio
Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
Company Announcement COPENHAGEN, Denmark; April 2, 2024 “ Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5...
Genmab has snared a lease to upsize its U.S. presence and create 300 new jobs as part of its Epkinly marketing push in diffuse large B-cell lymphoma.
Company Announcement COPENHAGEN, Denmark; March 25, 2024 “ Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5...
Company Announcement COPENHAGEN, Denmark; March 18, 2024 – Genmab A/S (Nasdaq: GMAB) announces that its share buy-back program has been completed on March 15, 2024 On February 14, 2024, Genmab...
Genmab Announces Initiation of Share Buy-Back Program